• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检测人血浆中的 13 种人参皂苷(Rb1、Rb2、Rc、Rd、Re、Rf、Rg1、Rg3、Rh2、F1、Compound K、20()-原人参二醇和 20()-原人参三醇)及红参提取物重复给药两周后在人体药代动力学研究中的应用

Detection of 13 Ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg3, Rh2, F1, Compound K, 20()-Protopanaxadiol, and 20()-Protopanaxatriol) in Human Plasma and Application of the Analytical Method to Human Pharmacokinetic Studies Following Two Week-Repeated Administration of Red Ginseng Extract.

机构信息

College of Pharmacy, Dankook University, Cheon-an 31116, Korea.

College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Korea.

出版信息

Molecules. 2019 Jul 18;24(14):2618. doi: 10.3390/molecules24142618.

DOI:10.3390/molecules24142618
PMID:31323835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6680484/
Abstract

We aimed to develop a sensitive method for detecting 13 ginsenosides using liquid chromatography-tandem mass spectrometry and to apply this method to pharmacokinetic studies in human following repeated oral administration of red ginseng extract. The chromatograms of Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg3, Rh2, F1, compound K (CK), protopanaxadiol (PPD), and protopanaxatriol (PPT) in human plasma were well separated. The calibration curve range for 13 ginsenosides was 0.5-200 ng/mL and the lower limit of quantitation was 0.5 ng/mL for all ginsenosides. The inter- and intra-day accuracy, precision, and stability were less than 15%. Among the 13 ginsenosides tested, nine ginsenosides (Rb1, Rb2, Rc, Rd, Rg3, CK, Rh2, PPD, and PPT) were detected in the human plasma samples. The plasma concentrations of Rb1, Rb2, Rc, Rd, and Rg3 were correlated with the content in red ginseng extract; however, CK, Rh2, PPD, and PPT were detected although they are not present in red ginseng extract, suggesting the formation of these ginsenosides through the human metabolism. In conclusion, our analytical method could be effectively used to evaluate pharmacokinetic properties of ginsenosides, which would be useful for establishing the pharmacokinetic-pharmacodymic relationship of ginsenosides as well as ginsenoside metabolism in humans.

摘要

我们旨在开发一种灵敏的液相色谱-串联质谱法检测 13 种人参皂苷的方法,并将该方法应用于红参提取物重复口服给药后的人体药代动力学研究。在人血浆中,Rb1、Rb2、Rc、Rd、Re、Rf、Rg1、Rg3、Rh2、F1、化合物 K(CK)、原人参二醇(PPD)和原人参三醇(PPT)的色谱图得到了很好的分离。13 种人参皂苷的校准曲线范围为 0.5-200ng/mL,所有人参皂苷的定量下限均为 0.5ng/mL。日内和日间准确度、精密度和稳定性均小于 15%。在所测试的 13 种人参皂苷中,有 9 种(Rb1、Rb2、Rc、Rd、Rg3、CK、Rh2、PPD 和 PPT)在人血浆样品中被检测到。Rb1、Rb2、Rc、Rd 和 Rg3 的血浆浓度与红参提取物中的含量相关;然而,尽管 CK、Rh2、PPD 和 PPT 不在红参提取物中存在,但它们被检测到,这表明这些人参皂苷是通过人体代谢形成的。总之,我们的分析方法可有效地用于评估人参皂苷的药代动力学特性,这对于建立人参皂苷的药代动力学-药效学关系以及人参皂苷在人体内的代谢非常有用。

相似文献

1
Detection of 13 Ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg3, Rh2, F1, Compound K, 20()-Protopanaxadiol, and 20()-Protopanaxatriol) in Human Plasma and Application of the Analytical Method to Human Pharmacokinetic Studies Following Two Week-Repeated Administration of Red Ginseng Extract.检测人血浆中的 13 种人参皂苷(Rb1、Rb2、Rc、Rd、Re、Rf、Rg1、Rg3、Rh2、F1、Compound K、20()-原人参二醇和 20()-原人参三醇)及红参提取物重复给药两周后在人体药代动力学研究中的应用
Molecules. 2019 Jul 18;24(14):2618. doi: 10.3390/molecules24142618.
2
Simultaneous quantification of twenty-one ginsenosides and their three aglycones in rat plasma by a developed UFLC-MS/MS assay: Application to a pharmacokinetic study of red ginseng.通过开发的超快速液相色谱-串联质谱法同时定量大鼠血浆中的21种人参皂苷及其3种苷元:在红参药代动力学研究中的应用。
J Pharm Biomed Anal. 2017 Apr 15;137:1-12. doi: 10.1016/j.jpba.2017.01.009. Epub 2017 Jan 6.
3
Pharmacokinetics of ginsenosides following repeated oral administration of red ginseng extract significantly differ between species of experimental animals.红参提取物重复口服给药后,人参皂苷的药代动力学在实验动物的不同物种间有显著差异。
Arch Pharm Res. 2020 Dec;43(12):1335-1346. doi: 10.1007/s12272-020-01289-0. Epub 2020 Nov 22.
4
Stereoselective and Simultaneous Analysis of Ginsenosides from Ginseng Berry Extract in Rat Plasma by UPLC-MS/MS: Application to a Pharmacokinetic Study of Ginseng Berry Extract.人参浆果提取物在大鼠血浆中的人参皂苷的立体选择性和同时分析:人参浆果提取物药代动力学研究的应用。
Molecules. 2018 Jul 23;23(7):1835. doi: 10.3390/molecules23071835.
5
Diversity of Ginsenoside Profiles Produced by Various Processing Technologies.不同加工工艺生产的人参皂苷成分多样性。
Molecules. 2020 Sep 24;25(19):4390. doi: 10.3390/molecules25194390.
6
Herb-Drug Interaction of Red Ginseng Extract and Ginsenoside Rc with Valsartan in Rats.红参提取物及人参皂苷 Rc 与缬沙坦在大鼠体内的药物-药物相互作用。
Molecules. 2020 Jan 31;25(3):622. doi: 10.3390/molecules25030622.
7
Tolerability and pharmacokinetics of ginsenosides Rb1, Rb2, Rc, Rd, and compound K after single or multiple administration of red ginseng extract in human beings.人参皂苷Rb1、Rb2、Rc、Rd及化合物K在人单次或多次服用红参提取物后的耐受性和药代动力学。
J Ginseng Res. 2020 Mar;44(2):229-237. doi: 10.1016/j.jgr.2018.10.006. Epub 2018 Oct 27.
8
Ginsenosides are active ingredients in with immunomodulatory properties from cellular to organismal levels.人参皂苷是人参中的活性成分,具有从细胞水平到机体水平的免疫调节特性。 (注:原英文文本“in with”表述有误,推测正确表述可能是“in ginseng”,按照此理解进行了翻译)
J Ginseng Res. 2022 Nov;46(6):711-721. doi: 10.1016/j.jgr.2021.12.007. Epub 2021 Dec 22.
9
Generation of ginsenosides Rg3 and Rh2 from North American ginseng.从西洋参中生成人参皂苷Rg3和Rh2。
Phytochemistry. 2004 Feb;65(3):337-44. doi: 10.1016/j.phytochem.2003.11.020.
10
Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice.人参根中人参二醇和人参三醇皂苷对小鼠卵清蛋白免疫反应的佐剂作用。
Vaccine. 2007 Jan 22;25(6):1114-20. doi: 10.1016/j.vaccine.2006.09.054. Epub 2006 Oct 5.

引用本文的文献

1
Unlocking ginsenosides' therapeutic power with polymer-based delivery systems: current applications and future perspectives.利用基于聚合物的递送系统释放人参皂苷的治疗潜力:当前应用与未来展望。
Front Pharmacol. 2025 Jul 10;16:1629803. doi: 10.3389/fphar.2025.1629803. eCollection 2025.
2
Compound K-enriched Korean red ginseng prevents lung cancer progression by targeting cancer cells and fibroblasts.富含化合物K的韩国红参通过靶向癌细胞和成纤维细胞来预防肺癌进展。
J Ginseng Res. 2025 Jul;49(4):438-450. doi: 10.1016/j.jgr.2025.03.010. Epub 2025 Apr 4.
3
LC-MS/MS quantification of 20(S)-protopanaxadiol in complex biological matrices for bioanalytical method validation and pharmacokinetic analysis.

本文引用的文献

1
Tolerability and pharmacokinetics of ginsenosides Rb1, Rb2, Rc, Rd, and compound K after single or multiple administration of red ginseng extract in human beings.人参皂苷Rb1、Rb2、Rc、Rd及化合物K在人单次或多次服用红参提取物后的耐受性和药代动力学。
J Ginseng Res. 2020 Mar;44(2):229-237. doi: 10.1016/j.jgr.2018.10.006. Epub 2018 Oct 27.
2
Tentative identification of 20()-protopanaxadiol metabolites in human plasma and urine using ultra-performance liquid chromatography coupled with triple quadrupole time-of-flight mass spectrometry.使用超高效液相色谱联用三重四极杆飞行时间质谱法对人血浆和尿液中20()-原人参二醇代谢物进行初步鉴定。
J Ginseng Res. 2019 Oct;43(4):539-549. doi: 10.1016/j.jgr.2018.03.005. Epub 2018 Apr 5.
3
用于生物分析方法验证和药代动力学分析的复杂生物基质中20(S)-原人参二醇的液相色谱-串联质谱定量分析
Sci Rep. 2025 May 13;15(1):16640. doi: 10.1038/s41598-025-01432-1.
4
Ginsenoside Rg1 in Parkinson's disease: from basic research to clinical applications.人参皂苷Rg1在帕金森病中的应用:从基础研究到临床应用
Front Pharmacol. 2025 Apr 16;16:1490480. doi: 10.3389/fphar.2025.1490480. eCollection 2025.
5
Impact of ginsenoside Rb1 on gut microbiome and associated changes in pharmacokinetics in rats.人参皂苷 Rb1 对大鼠肠道微生物组的影响及其相关药代动力学变化。
Sci Rep. 2024 Sep 10;14(1):21168. doi: 10.1038/s41598-024-72225-1.
6
Systematic studies on the kinetic process of 20(S)-protopanaxadiol in rats and dogs: absorption, distribution, metabolism and excretion.大鼠和犬体内20(S)-原人参二醇动力学过程的系统研究:吸收、分布、代谢和排泄
Front Pharmacol. 2024 Jun 20;15:1430780. doi: 10.3389/fphar.2024.1430780. eCollection 2024.
7
Ginsenoside Rg1 Induces Autophagy in Colorectal Cancer through Inhibition of the Akt/mTOR/p70S6K Pathway.人参皂苷 Rg1 通过抑制 Akt/mTOR/p70S6K 通路诱导结直肠癌细胞自噬。
J Microbiol Biotechnol. 2024 Apr 28;34(4):774-782. doi: 10.4014/jmb.2310.10043. Epub 2024 Jan 12.
8
Prevention of colistin-induced neurotoxicity: a narrative review of preclinical data.黏菌素诱导的神经毒性的预防:临床前数据的叙述性综述
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):3709-3727. doi: 10.1007/s00210-023-02884-w. Epub 2023 Dec 13.
9
Myogenesis Effects of RGX365 to Improve Skeletal Muscle Atrophy.RGX365 对改善骨骼肌萎缩的成肌作用。
Nutrients. 2023 Oct 9;15(19):4307. doi: 10.3390/nu15194307.
10
Compound K Production: Achievements and Perspectives.化合物K的生产:成就与展望
Life (Basel). 2023 Jul 14;13(7):1565. doi: 10.3390/life13071565.
Non-clinical pharmacokinetic behavior of ginsenosides.
人参皂苷的非临床药代动力学行为。
J Ginseng Res. 2019 Jul;43(3):354-360. doi: 10.1016/j.jgr.2018.06.001. Epub 2018 Jun 18.
4
Enhanced Intestinal Permeability and Plasma Concentration of Metformin in Rats by the Repeated Administration of Red Ginseng Extract.重复给予红参提取物对大鼠肠道通透性及二甲双胍血浆浓度的影响
Pharmaceutics. 2019 Apr 18;11(4):189. doi: 10.3390/pharmaceutics11040189.
5
Effects of Red Ginseng Extract on the Pharmacokinetics and Elimination of Methotrexate via Mrp2 Regulation.红参提取物通过调节 MRP2 对甲氨蝶呤药代动力学和消除的影响。
Molecules. 2018 Nov 12;23(11):2948. doi: 10.3390/molecules23112948.
6
A Comprehensive In Vivo and In Vitro Assessment of the Drug Interaction Potential of Red Ginseng.红参的体内和体外药物相互作用潜力的综合评估
Clin Ther. 2018 Aug;40(8):1322-1337. doi: 10.1016/j.clinthera.2018.06.017. Epub 2018 Aug 2.
7
Gut microbiota-mediated pharmacokinetics of ginseng saponins.肠道微生物群介导的人参皂苷药代动力学
J Ginseng Res. 2018 Jul;42(3):255-263. doi: 10.1016/j.jgr.2017.04.011. Epub 2017 Apr 28.
8
Effect of Korean Red Ginseng in chronic liver disease.韩国红参对慢性肝病的影响。
J Ginseng Res. 2017 Oct;41(4):450-455. doi: 10.1016/j.jgr.2016.11.004. Epub 2017 Jan 5.
9
Role of ginsenosides, the main active components of , in inflammatory responses and diseases.人参皂苷(人参的主要活性成分)在炎症反应和疾病中的作用。
J Ginseng Res. 2017 Oct;41(4):435-443. doi: 10.1016/j.jgr.2016.08.004. Epub 2016 Aug 18.
10
Biotransformation of major ginsenosides in ginsenoside model culture by lactic acid bacteria.乳酸菌对人参皂苷模型培养物中主要人参皂苷的生物转化作用。
J Ginseng Res. 2017 Jan;41(1):36-42. doi: 10.1016/j.jgr.2015.12.008. Epub 2015 Dec 28.